(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

FORMA DE DOSAGEM ORAL SÓLIDA CONTENDO ACETAMINOFENO E IBUPROFENO

PublicadaUtility ModelPCT · US2020020112

Application data

Number

122024014908

Type

Utility Model

Filing

02/27/2020

Publication

10/22/2024

PCT

US2020020112

Progress at the INPI

  1. Filing02/27/20
  2. Publication10/22/24
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was published in the RPI gazette on 10/22/2024 and is now open to any interested party. It moves on to technical examination at the INPI.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 10/22/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AFT PHARMACEUTICALS LIMITED

NZ

See this company's full portfolio

Inventors

M. C. (pessoa física)

US

M. M. (pessoa física)

US

Technical data

Priority claims

US

16/287,836 · 02/27/2019

Abstract

FORMA DE DOSAGEM ORAL SÓLIDA CONTENDO ACETAMINOFENO E IBUPROFENO. A invenção consiste em uma forma de dosagem oral sólida, por exemplo, um comprimido compreendendo 325 mg de acetaminofeno e 97,5 mg de ibuprofeno, ou 500 mg de acetaminofeno e 150 mg de ibuprofeno, em que o ibuprofeno tem um [D50] entre 2 e 8 µm, um [D10] entre 1 e 3 µm e um [D90] entre 4 e 16 µm.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Publicação do pedido de patente

#3.1

10/22/2024

RPI 2807

Notificação de pedido dividido

#2.4

10/08/2024

RPI 2805

Requerimento de pedido de patente

#2.10

Número de Protocolo '870240061183' em 19/07/2024 16:28 (WB)

07/30/2024

RPI 2795

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.